Allergy Therapeutics PLC banner

Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 10.5 GBX
Market Cap: £664.9m

Allergy Therapeutics PLC
Goodwill

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Allergy Therapeutics PLC
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
Allergy Therapeutics PLC
LSE:AGY
Goodwill
£3.3m
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
1%
GlaxoSmithKline PLC
LSE:GSK
Goodwill
£7B
CAGR 3-Years
0%
CAGR 5-Years
-8%
CAGR 10-Years
3%
AstraZeneca PLC
LSE:AZN
Goodwill
$21.2B
CAGR 3-Years
2%
CAGR 5-Years
12%
CAGR 10-Years
6%
Hikma Pharmaceuticals PLC
LSE:HIK
Goodwill
$393m
CAGR 3-Years
0%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Animalcare Group PLC
LSE:ANCR
Goodwill
£72.6m
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
19%
A
Alliance Pharma PLC
LSE:APH
Goodwill
£12.7m
CAGR 3-Years
-26%
CAGR 5-Years
-5%
CAGR 10-Years
13%
No Stocks Found

Allergy Therapeutics PLC
Glance View

Market Cap
664.9m GBX
Industry
Pharmaceuticals

Allergy Therapeutics Plc is a biotechnology company. The company is headquartered in Worthing, West Sussex and currently employs 601 full-time employees. The company went IPO on 2004-10-11. The firm is focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines. Its segments include Central Europe, which include segments, such as Germany, Austria, Switzerland and the Netherlands; Southern Europe, which includes Italy, Spain and Other; the United Kingdom, and Rest of World. The company sells both injectable and sublingual allergen-specific immunotherapies. Its pipeline candidates include Grass MATA MPL, Birch MATA MPL, Ragweed MATA MPL, Trees MATA MPL and Peanut SCIT. Its vaccine candidates outside allergy include disease areas, including cancer, asthma, atopic dermatitis and psoriasis. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Venomil, VLP Peanut and ImmunoBON.

AGY Intrinsic Value
0.7 GBX
Overvaluation 93%
Intrinsic Value
Price

See Also

What is Allergy Therapeutics PLC's Goodwill?
Goodwill
3.3m GBP

Based on the financial report for Jun 30, 2025, Allergy Therapeutics PLC's Goodwill amounts to 3.3m GBP.

What is Allergy Therapeutics PLC's Goodwill growth rate?
Goodwill CAGR 10Y
1%

Over the last year, the Goodwill growth was 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett